Current Options for Medication Management
WebcastFaculty
OVERVIEW
Current Options for Medication Management is organized by Obesity Medicine Association (OMA) and will be held during Apr 09, 2016 - Mar 28, 2019. This CME Conference has been approved for a maximum of 3.00 AMA PRA Category 1 Credits.
Conference Description :
Practical Medication Management and Currently Available Options for Obesity Treatment consists of 3 presentations:
In Practical Medication Management for Obesity Treatment, Dr. Lazarus will discuss using FDA-approved anti-obesity medications as part of a patient's overall treatment for overweight/obesity.
In Obesity Medications: What Are the Current Options?, Dr. Butsch will present a comprehensive review of the currently available anti-obesity medications that may be used as part of a patient's individualized treatment plan.
Drs. Butsch and Lazarus will then come together to address attendee questions, during the spring 2016 Pharmacotherapy Panel Discussion.
Conference Objectives are:
• Learn to identify medications that are iatrogenic for weight gain and select better alternatives.
• Review all currently available FDA-approved anti-obesity medications.
• Develop an algorithm to compare treatment options through the use of patient case discussions.
• Understand that combination therapies may target limited groups of patients effectively.
• Identify new approved anti-obesity medications.
• Identify emerging anti-obesity agents in clinical development.
• Recognize patient heterogeneity and the need for individualized treatments given variation in response.
Additional details will be posted as soon as they are available.
Conference Description :
Practical Medication Management and Currently Available Options for Obesity Treatment consists of 3 presentations:
In Practical Medication Management for Obesity Treatment, Dr. Lazarus will discuss using FDA-approved anti-obesity medications as part of a patient's overall treatment for overweight/obesity.
In Obesity Medications: What Are the Current Options?, Dr. Butsch will present a comprehensive review of the currently available anti-obesity medications that may be used as part of a patient's individualized treatment plan.
Drs. Butsch and Lazarus will then come together to address attendee questions, during the spring 2016 Pharmacotherapy Panel Discussion.
Conference Objectives are:
• Learn to identify medications that are iatrogenic for weight gain and select better alternatives.
• Review all currently available FDA-approved anti-obesity medications.
• Develop an algorithm to compare treatment options through the use of patient case discussions.
• Understand that combination therapies may target limited groups of patients effectively.
• Identify new approved anti-obesity medications.
• Identify emerging anti-obesity agents in clinical development.
• Recognize patient heterogeneity and the need for individualized treatments given variation in response.
Additional details will be posted as soon as they are available.
SPECIALITIES
Pharmacy and MedicineHealthcare ManagementRELATED ONLINE COURSES
Quick Links